Lexaria Bioscience (LEXX) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to -$1.6 million.
- Lexaria Bioscience's Profit After Tax rose 4097.81% to -$1.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$10.8 million, marking a year-over-year decrease of 4736.63%. This contributed to the annual value of -$11.9 million for FY2025, which is 10506.36% down from last year.
- Latest data reveals that Lexaria Bioscience reported Profit After Tax of -$1.6 million as of Q4 2025, which was up 4097.81% from -$2.7 million recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's Profit After Tax registered a high of -$652733.0 during Q1 2024, and its lowest value of -$3.8 million during Q2 2025.
- Its 5-year average for Profit After Tax is -$2.0 million, with a median of -$1.8 million in 2024.
- As far as peak fluctuations go, Lexaria Bioscience's Profit After Tax surged by 5019.73% in 2024, and later tumbled by 31624.55% in 2025.
- Over the past 5 years, Lexaria Bioscience's Profit After Tax (Quarter) stood at -$2.0 million in 2021, then grew by 11.69% to -$1.8 million in 2022, then soared by 33.02% to -$1.2 million in 2023, then crashed by 128.4% to -$2.7 million in 2024, then skyrocketed by 40.98% to -$1.6 million in 2025.
- Its Profit After Tax stands at -$1.6 million for Q4 2025, versus -$2.7 million for Q3 2025 and -$3.8 million for Q2 2025.